Effect of Rivaroxaban verses Low Molecular Weight Heparin on Preventing Deep Vein Thrombosis in Postoperative Hip or Knee Arthroplasty

CAI Zhencun,CHANG Jinqiu,PIAO Chengzhe

DOI: https://doi.org/10.3969/j.issn.1008-2344.2013.02.011

2013-01-01

Abstract:Objective:To investigate the clinical efficacy of rivaroxaban verses low molecular weight heparin(LMWH) on preventing deep vein thrombosis(DVT) in postoperative hip or knee arthroplasty.Methods:From Mar 2011 to Dec 2012,102 patients with hip or knee arthroplasty by operation in our hospital were selected and randomly divided into two groups,rivaroxaban and LMWH groups,51 patinets in each group.The rivaroxaban group was given oral rivaroxaban 10 mg/d at postoperative 6 h,once a day for continuous 2 weeks.The LMWH group was given LMWH 4 100 IU/d with in postoperative 6 h,by subcutaneous injection for continuous 2 weeks.The DVT formation was detected by color Doppler ultra sound and compared between two groups after 2 week treatment.APTT,PT and PLT were detected at preoperation and postoperation and drainage amount was recorded at postoperation.Results:Seven patients had DVT in the LMWH group with the occurrence rate of 13.7%and 3 patients had DVT in the rivaroxaban group with the occurrence rate of 5.9%.There was statistical difference between two groups(P<0.05).The rivaroxaban group had no obvious adverse reactions.Conclusion:Rivaroxaban can effectively prevent postoperative DVT in hip or knee arthroplasty and has good security with less adverse reactions,which can be used in clinical practice.